You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 15, 2025

Drug Price Trends for NDC 63323-0089


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 63323-0089

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 63323-0089

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a drug identified by the NDC 63323-0089, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product. The NDC for the drug in question, 63323-0089, breaks down into the labeler code, product code, and package code[1][5].

Identifying the Drug

The NDC 63323-0089 can be used to identify the specific drug product. Here’s a breakdown:

  • Labeler Code: The first segment (63323) identifies the labeler, which is the firm that manufactures, repackages, or relabels the drug.
  • Product Code: The second segment (008) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment (9) identifies the package size and type.

Market Trends in the Pharmaceutical Industry

To project the price of this drug, it is essential to consider current market trends in the pharmaceutical industry.

Drug Price Inflation

Recent projections indicate that drug price inflation is expected to rise. Vizient, Inc. has estimated a 3.81% overall drug price inflation rate for 2025, driven in part by the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2][4].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which include drugs for complex or chronic conditions, are a significant factor in the rising costs. These medications, such as those for diabetes and obesity (e.g., semaglutide), are seeing increased utilization and have been approved for additional indications, contributing to higher spend[2][4].

Biosimilars

Biosimilars, which are biologic products that are highly similar to an already-approved biologic, are expected to grow in market share. However, their impact on the price of the specific drug identified by NDC 63323-0089 would depend on whether biosimilars are available for this particular product and their adoption rates[4].

Specific Drug Analysis

Drug Category and Usage

To accurately project the price, one must determine the category and usage of the drug. If the drug falls under the category of specialty pharmaceuticals or has recently expanded indications, it is likely to see increased prices.

Example: Semaglutide

For instance, semaglutide (Ozempic® and Wegovy®), which treats diabetes and obesity and has recently been approved for reducing the risk of major adverse cardiovascular events, saw a 77% increase in spend compared to the previous year. If the drug in question has similar market dynamics, it could experience significant price increases[2].

Regulatory and Listing Requirements

FDA Listings

The drug must be listed in the FDA's National Drug Code Directory, which contains information on active and certified finished and unfinished drugs. Any changes in the listing status or compliance with FDA regulations can impact the drug's market availability and pricing[1][5].

Price Projections

Given the current trends:

  • General Inflation: A 3.81% overall drug price inflation rate is projected for 2025[2].
  • Specialty Pharmaceuticals: If the drug falls into this category, it may see higher price increases, potentially exceeding the general inflation rate[4].
  • Biosimilars: If biosimilars are available for this drug, they might mitigate some of the price increases, but this would depend on their market penetration and adoption rates[4].

Key Takeaways

  • Market Trends: The pharmaceutical industry is experiencing rising costs driven by specialty pharmaceuticals and expanding indications of existing drugs.
  • Regulatory Compliance: The drug's listing status in the FDA's NDC Directory and compliance with regulatory requirements are crucial for its market presence.
  • Price Projections: A general increase of 3.81% is projected, but specific drugs, especially those in the specialty category, may see higher increases.

FAQs

1. What is the National Drug Code (NDC) and how is it used? The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product. It is used by the FDA to track and regulate drug products.

2. How does drug price inflation affect the pharmaceutical market? Drug price inflation can significantly impact the pharmaceutical market by increasing costs for providers and consumers, affecting budget allocations, and influencing the adoption of new and existing medications.

3. What role do biosimilars play in the pharmaceutical market? Biosimilars are biologic products that are highly similar to already-approved biologics. They can reduce costs by offering cheaper alternatives to expensive biologic drugs and are expected to grow in market share.

4. How do expanding indications for existing drugs impact their prices? Expanding indications for existing drugs can lead to increased utilization and higher prices due to increased demand and the drug's broader application in clinical practice.

5. What is the significance of the FDA's National Drug Code Directory? The FDA's National Drug Code Directory contains critical information on all listed drug products, including their NDC numbers, and is essential for regulatory compliance and market tracking.

Sources

  1. FDA: National Drug Code Database Background Information - FDA
  2. Vizient, Inc.: Vizient projects drug price inflation at 3.81%
  3. Global Pharma Tek: Top 12 Pharmaceutical Industry Trends in 2024
  4. Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals
  5. FDA: National Drug Code Directory - FDA

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.